CAR-T cell therapy in spheroids
How do CAR-T cells attack tumors in real-time? Pixel electrical imaging captures the dynamic interactions between T cells and tumor spheroids, revealing both structural changes and immune cell activity.
In this experiment, HeLa-CD19 spheroids were incubated with CD19-targeting T cells from ProMab Biotechnologies for 72 hours. The left panel shows an untreated spheroid growing over time, while the right demonstrates CAR-T cells reducing the tumor mass within 24 hours after their addition. Pixel enables visualization of T cell movement as well as their impact on the tumor microenvironment.